Albireo
2008
FOUNDED
PUBLIC
STATUS
31-40
EMPLOYEES
ALBO
STOCK SYMBOL
1
INVESTMENTS
$35.61
SHARE PRICE
(As of Monday Closing)
Description
Albireo Pharma Inc is a development-stage pharmaceutical company. It engages in the research and development of drug reformulation technology. The company product portfolio includes Pediatric Liver, Adult Liver, and Gastrointestinal.
Website
Formerly Known As
Biodel
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Stock Exchange
NAS
Primary Office
- 50 Milk Street
- 16th floor
- Boston, MA 02109
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Albireo’s full profile, request a free trial.
Albireo Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $19.10 - $38.69 | $429M | $35.98 | -$5.12 | 52.2K | 12M |
Albireo Financials Summary
|
In Thousands,
USD |
TTM
31-Mar-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 223,473 | 240,391 | 196,809 | 80,552 |
| Revenue | 2,108 | 12,740 | 1 | 0 |
| EBITDA | (55,995) | (41,208) | (24,207) | (13,886) |
| Net Income | (61,149) | (46,111) | (24,414) | (13,755) |
| Total Assets | 172,978 | 185,466 | 73,224 | 28,869 |
| Total Debt | 3,075 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Albireo Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Albireo‘s full profile, request access.
Request full access to PitchBookAlbireo Competitors (5)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Acceleron Pharma | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 00000000 | 00000 |
| 000000 000000000 | Formerly Angel backed | New York, NY | 00 | 00.000 | 00000000 | 00.000 |
| 00000 | Formerly VC-backed | Dublin, Ireland | 00000 | 00000 | 000000&0 | 00000 |
| 00000000 000000000 | Corporate Backed or Acquired | Cambridge, MA | 000 | 00000 | 000000000 | 00000 |
| 0000000 0000000000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 00000000000 | 00000 |
Albireo Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 | 03-Nov-2016 | 000000000000000000 | Pharmaceuticals | 000000 000000 |
Albireo Executive Team (16)
8 Former Executives
You’re viewing 5 of 16 executives. Get the full list »Albireo Board Members (10)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Davey Scoon | Biodel | Board Member | 000 0000 | |
| David Chiswell Ph.D | Self | Chairman | 000 0000 | |
| Elisabeth Bjork | Self | Board Member | 000 0000 | |
| Julia Brown | Albireo | Board Member | 000 0000 | |
| Michael Gutch Ph.D | Self | Board Member | 000 0000 |
3 Former Board Members
You’re viewing 5 of 10 board members. Get the full list »